Next Article in Journal
Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study
Previous Article in Journal
Cardiovascular Characteristics of Zucker Fatty Diabetes Mellitus Rats, an Animal Model for Obesity and Type 2 Diabetes
 
 
Article
Peer-Review Record

Combination of Sanguisorbigenin and Conventional Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus: Inhibition of Biofilm Formation and Alteration of Cell Membrane Permeability

Int. J. Mol. Sci. 2022, 23(8), 4232; https://doi.org/10.3390/ijms23084232
by Shu Wang 1, Xiang-Qian Liu 2, Ok-Hwa Kang 1 and Dong-Yeul Kwon 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2022, 23(8), 4232; https://doi.org/10.3390/ijms23084232
Submission received: 11 March 2022 / Revised: 8 April 2022 / Accepted: 8 April 2022 / Published: 11 April 2022

Round 1

Reviewer 1 Report

Well written paper with great method explanation.

My main comment is regarding figure 1:

What is your detection limit and dynamic range for CFU counts?

Figures show log of 0 which is infinite. Authors need to start their vertical axis from where their detection limit is. For example if your colony counter is able to count 100 CFUs then your detection limit is 2. Please correct all the corresponding graphs.

Author Response

"Please see the attachment"

Author Response File: Author Response.docx

Reviewer 2 Report

The paper uses solid methology and is overall of interest, however, I am not entirely convinced that the number of methods used, the only once compound (sanguisorbigenin) tested and the limited number of isolates enrolled in the study allow for far-reaching conclusions that would warrant publication in this high-impact and high-quality journal. Overall, the novelty and significance of the results needs to be further highlighted/clarified, otherwise the MS should not be considered for publication.

General:

biological names (bacteria, plants) should be in italics, please follow international rules for taxonomy and nomenclature

latin terms (in vitro, in vivo) should be in italics

  1. Introduction

L33-34: please elaborate on the epidemiology of MRSA in the context of human infections

L39-L41: this sentence is very akward and repetitive, please rephrase it

L42-44: the authors should elaborate more on the global significance of AMR using current literature sources

L45-55: the authors should elaborate more on the composition of bacterial biofilms and their significance, as the present version of this part is quite basic. please discuss the correlation between biofilm-formation and MDR in staphylococci using current literature sources

  1. Results

the data presented in Table 1. is akward and hard to read

Figures 1.-3. are of poor quality and visibility, they need to be improved

panes from Fig. 4 need to be enlarged for better visibility

Discussion:

L163-165: this is a strong statement, which has – in my opition – not been entirely proven by the present results

L192-194: why didnt you inlcude these results in the present ms?

Methods:

for the assessment of combination, more current indices (e.g., CI, combination index) have been proposed, which better reflect biological interactions between compounds

Author Response

"Please see attachment"

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The authors have addressed most of my concerns regarding the initial version of the manuscript.

Please consider including a very recent and comprehensive review on AMR in the introduction at L45-54:

https://www.sciencedirect.com/science/article/pii/S1876034121003403

Back to TopTop